Abstract
Bilateral synchronous paratesticular leiomyoma (BSPL) is a rare tumor that originates from smooth muscle cells in the paratesticular region. Four BSPL cases have been reported sporadically, starting with the 1991 report by Aus and Boiesen. Herein, we report the case of a 60-year-old male with a bilateral scrotal mass with a maximum size of 7.5 cm. Histological examination revealed oval to spindle-shaped tumor cells with a fascicular growth pattern. Immunohistochemically, the tumor cells were positive for α-smooth muscle actin. The pathological diagnosis was a leiomyoma. Based on the simultaneous bilateral nature of the disease, BSPL was diagnosed. In conclusion, we encountered a rare case of BSPL, and our report may contribute to the understanding of this disease.
© 2023 The Author(s). Published by S. Karger AG, Basel
References
Billings SD, Folpe AL, Weiss SW. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes. Am J Surg Pathol. 2001 Sep;25(9):1134–42.
Lioe TF, Biggart JD. Tumours of the spermatic cord and paratesticular tissue. A clinicopathological study. Br J Urol. 1993 May;71(5):600–6.
Albert PS, Mininberg DT. Leiomyoma of the tunica albuginea. J Urol. 1972 May;107(5):869–71.
Aus G, Boiesen PT. Bilateral leiomyoma of the tunica albuginea. Case report. Scand J Urol Nephrol. 1991;25(1):79–80.
Lia-Beng T, Wei-Wuang H, Biing-Rorn C, Chia-Chun T. Bilateral synchronous leiomyomas of the testicular tunica albuginea. A case report and review of the literature. Int Urol Nephrol. 1996;28(4):549–52.
Wang AX, Feng SL, Chang JW. Leiomyomas of the bilateral tunica albuginea of testes: a case report. Int J Clin Exp Pathol. 2015;8(8):9703–5.
Fernandez A, Krishnamoorthy S, Muralitharan S, Johnson T, Ramanan V. Bilateral synchronous paratesticular leiomyoma: a rare entity. J Clin Diagn Res. 2017 Apr;11(4):PD05–PD06.
Leonhardt WC, Gooding GA. Sonography of epididymal leiomyoma. Urology. 1993 Mar;41(3):262–4.
Siegal GP, Gaffey TA. Solitary leiomyomas arising from the tunica dartos scroti. J Urol. 1976 Jul;116(1):69–71.
Heidenreich A, Moul JW, Srivastava S, Engelmann UH. Synchronous bilateral testicular tumour: nonseminomatous germ cell tumours and contralateral benign tumours. Scand J Urol Nephrol. 1997 Aug;31(4):389–92.
Raza M, Vinay HG, Ali M, Siddesh G. Bilateral paratesticular liposarcoma - a rare case report. J Surg Tech Case Rep. 2014 Jan;6(1):15–7.
Moradi A, Farhoumand D, Bouzari B, Shakiba B. Simultaneous bilateral testicular metastases from renal clear cell carcinoma: a rare presentation in von hippel-lindau disease. J Kidney Cancer VHL. 2022;9(2):19–21.
Mehine M, Makinen N, Heinonen HR, Aaltonen LA, Vahteristo P. Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril. 2014 Sep;102(3):621–9.
Tammela TL, Karttunen TJ, Makarainen HP, Hellstrom PA, Mattila SI, Kontturi MJ. Intrascrotal adenomatoid tumors. J Urol. 1991 Jul;146(1):61–5.
Author Contacts
Akira Ishikawa, a-ishikawa@hiroshima-u.ac.jp
Article / Publication Details
Received: October 04, 2022
Accepted: December 16, 2022
Published online: February 17, 2023
Issue release date: January – December
Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0
eISSN: 1662-6575 (Online)
For additional information: https://www.karger.com/CRO
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Comments (0)